UPDATE: Phibro Animal Health (PAHC) Tops Q4 EPS by 2c; Guides FY17 EPS Below Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year
August 29, 2016 4:40 PM EDTTEANECK, N.J., Aug. 29, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its fourth quarter and fiscal year ended June 30, 2016. It also provided guidance for its fiscal year ending June 30, 2017.
Highlights for the June 2016 quarter (compared to the June 2015 quarter) Net sales of $189 million, an increase of 2%Net income of $15 million, an increase of 46%Diluted EPS of $0.38, an increase of 46%Adjusted EBITDA of $28 million, an increase of 4%Adjusted diluted EPS of $0.40, a decrease of... More